Recent regulatory scrutiny in Germany has cast a spotlight on misoprostol (Angusta) and its role in labour induction, raising significant safety concerns. As this conversation unfolds across Europe, healthcare professionals are re-evaluating their induction protocols and looking to non-pharmacological methods like DILAPAN-S as a safer alternative.

Your Quarterly Update on Innovations in Women’s Health Welcome to the July 2025 edition of AGHeadlines , where we share the latest...

Today, on the International Day of Action for Women’s Health , we stand in recognition and deep gratitude for the tireless work of...

In this edition: - The WID-easy test - New Evidence and Data - Upcoming Events - 4DryField PH Distributor Change

This article provides guidance on when and how to use the AmniSure® test in clinical practice.

Preterm birth (PTB) is one of the leading causes of neonatal mortality and morbidity worldwide. Early identification of women and...

What activities counts towards your CPD hours? Find links to free learning resources and NMC approved courses in this article.